4/A: Eli Lilly Executive Corrects Share Withholding
Insider Transaction Amendment
Eli Lilly & Co. EVP & CIDO Diogo Rau's beneficial ownership adjusted due to correction of over-withheld tax shares.
Summary
- Diogo Rau, Executive Vice President and Chief Information and Digital Officer (EVP & CIDO) of Eli Lilly & Co. (LLY), filed an amendment to a previous Form 4.
- The amendment reports an adjustment of 4,599.164 shares of Common Stock that were acquired by Rau.
- These shares were previously over-withheld from Rau to cover tax obligations due to an administrative error.
- The transaction date for this adjustment was February 9, 2026, with a price of $1,044.67 per share.
- Following this reported transaction, Rau beneficially owns 26,396.534 shares of Common Stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. While an administrative error occurred, it was corrected, and the filing primarily serves to update beneficial ownership records, with no material impact on company operations or financial health.
Positives
- The reporting person, Diogo Rau, recovered 4,599.164 shares of Common Stock that were previously over-withheld for tax obligations, increasing his beneficial ownership.
Negatives
- An administrative error led to the initial over-withholding of shares for tax obligations.
Risks
- The filing indicates an administrative error in the initial withholding of shares for tax obligations, which, while corrected, points to a potential for internal process discrepancies.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Management Comments
- The amendment is being filed to report an adjustment of shares withheld from the Reporting Person to cover tax obligations, which amount was previously over-withheld due to an administrative error.
Industry Context
StockSavvy.ai notes that this Form 4/A filing details an administrative correction to an executive's beneficial ownership, a routine compliance matter for publicly traded companies. It does not reflect broader industry trends or competitive positioning.
Comparison to Industry Standards
- Administrative errors in share withholding, while undesirable, are not uncommon across industries and typically corrected through such amendments. This specific event does not provide a basis for comparison to operational or financial performance benchmarks of comparable companies like Pfizer, Johnson & Johnson, or Novartis.
Stakeholder Impact
- Shareholders: Minimal impact, as this is an administrative correction to an executive's personal shareholdings and does not affect the company's operational or financial performance.
- Employees: No direct impact mentioned.
- Customers: No direct impact mentioned.
- Suppliers: No direct impact mentioned.
- Creditors: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 02/09/2026 | Transaction date for the acquisition of shares due to tax withholding adjustment. |
| 02/11/2026 | Date the original Form 4 was filed, which this amendment corrects. |
| 02/12/2026 | Signature date of the reporting person for this amendment. |
Keywords
Eli Lilly, LLY, Form 4, Insider Transaction, Beneficial Ownership, Executive Compensation, Tax Withholding, Administrative Error
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.